OKYO Pharma (OKYO) 10% Owner Gabriele M. Cerrone Buys 25,000 Shares
$OKYO · OKYO Pharma LtdResearch Summary
AI-generated summary of this SEC filing
OKYO Pharma (OKYO) 10% Owner Gabriele M. Cerrone Buys 25,000 Shares
What Happened
Gabriele M. Cerrone, a reported 10% owner of OKYO Pharma Ltd (OKYO), purchased 25,000 shares in an open-market transaction on July 20, 2026 at $1.40 per share, for a total of $35,000. The Form 4/A filed August 7, 2026 amends a prior Form 4 (filed July 21, 2026) solely to correct the transaction code; the reported purchase details themselves are unchanged. Purchases by insiders are often viewed by investors as a potentially bullish sign, though no motive is stated.
Key Details
- Transaction date and price: July 20, 2026 — 25,000 shares at $1.40 each ($35,000 total).
- Filing: Form 4/A filed August 7, 2026 to correct the transaction code from the original Form 4 filed July 21, 2026.
- Shares owned after transaction: Not disclosed in this filing.
- Insider status: Cerrone is a 10% owner (major shareholder), not an executive title reported here.
- No footnotes in the filing indicate a 10b5-1 plan, tax withholding, or derivative/option activity; the amendment only corrects the transaction code.
Context
As a 10% owner, Cerrone is a significant shareholder; purchases by large holders can be meaningful to investors but do not by themselves explain intent. This filing is an amendment correcting reporting details, not the underlying trade, so the economic transaction occurred on July 20, 2026 as reported.